SCHEMBL7079062

SCHEMBL7079062

Oc1ccc2ccccc2c1-c1ccccn1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.53
SMN1; SMN2 Q16637 5/20 0.53
LMNA P02545 4/20 0.53
MAPT P10636 4/20 0.53
TDP1 Q9NUW8 4/20 0.53
POLB P06746 3/20 0.53
NPSR1 Q6W5P4 3/20 0.53
NPC1 O15118 3/20 0.53
ALDH1A1 P00352 3/20 0.53
HPGD P15428 3/20 0.53
HTT P42858 3/20 0.53
L3MBTL1 Q9Y468 3/20 0.53
HSP90AA1 P07900 2/20 0.53
OPRK1 P41145 2/20 0.53
ALOX12 P18054 1/20 0.53
KMT2A Q03164 2/20 0.49
MEN1 O00255 1/20 0.49
GAA P10253 1/20 0.49
PTPN22 Q9Y2R2 1/20 0.48
TP53 P04637 3/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28343361 0.91 KDM4E (0.49) KDM4ESMN1; SMN2LMNAMAPTTDP1
SCHEMBL14198212 0.83 PTPN22 (0.50) KDM4EMAPTTDP1POLBALDH1A1
SCHEMBL21585465 0.82 CYP1A1 (0.56) KDM4ESMN1; SMN2LMNAMAPTTDP1
SCHEMBL6453905 0.82 SMN1; SMN2 (0.61) KDM4ESMN1; SMN2LMNAMAPTTDP1
SCHEMBL6451167 0.82 TP53 (0.63) KDM4ESMN1; SMN2LMNAMAPTPOLB
SCHEMBL28120750 0.82 KDM4E (0.62) KDM4ESMN1; SMN2LMNAMAPTTDP1
SCHEMBL21585463 0.81 CYP1A1 (0.54) KDM4ESMN1; SMN2LMNAMAPTTDP1
SCHEMBL21274321 0.81 KDM4E (0.50) KDM4ESMN1; SMN2LMNAMAPTTDP1
SCHEMBL13542407 0.80 KDM4E (0.48) KDM4ESMN1; SMN2LMNAMAPTTDP1
SCHEMBL29362162 0.80 PTPN22 (0.65) KDM4EMAPTTDP1POLBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8900722-B2 OLED device employing alkali metal cluster compounds GLOBAL OLED TECHNOLOGY LLC (US) 2014-12-02 US disclosed
US-20090142618-A1 OLED DEVICE EMPLOYING ALKALI METAL CLUSTER COMPOUNDS GLOBAL OLED TECHNOLOGY LLC 2009-06-04 US disclosed
WO-2003060192-A1 NON-TOXIC CORROSION-PROTECTION RINSES AND SEALS BASED ON COBALT UNIVERSITY OF DAYTON (US) 2003-07-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090142618-A1 OLED DEVICE EMPLOYING ALKALI METAL CLUSTER COMPOUNDS OCIAD2, OCIAD1, OSTC KDM4E 3395/4885SMN1; SMN2 4517/4885LMNA 4600/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.